131 related articles for article (PubMed ID: 4438832)
1. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma.
Murphy GP; Williams PD
Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832
[No Abstract] [Full Text] [Related]
2. Evaluation of hexamethylmelamine in murine renal cell carcinoma model.
Williams PD; Burdick J; Murphy GP
Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):399-407. PubMed ID: 4818383
[No Abstract] [Full Text] [Related]
3. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
Hrushesky WJ; Murphy GP
J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582
[No Abstract] [Full Text] [Related]
4. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
Williams PD; Kantor P; Murphy GP
Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
[TBL] [Abstract][Full Text] [Related]
5. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
[No Abstract] [Full Text] [Related]
6. Murine renal cell carcinoma: a suitable human model.
Murphy GP
Prog Clin Biol Res; 1982; 100():175-206. PubMed ID: 6216486
[TBL] [Abstract][Full Text] [Related]
7. The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma.
Williams PD; Murphy GP
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):153-61. PubMed ID: 6844733
[TBL] [Abstract][Full Text] [Related]
8. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
Mayo JG
Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
[No Abstract] [Full Text] [Related]
9. Chemotherapy of advanced renal cell carcinoma with vinblastine and CCNU.
Merrin C; Mittelman A; Fanous N; Walsman Z; Murphy GP
J Urol; 1975 Jan; 113(1):21-3. PubMed ID: 1113389
[TBL] [Abstract][Full Text] [Related]
10. Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.
Herr HW; Huffman JL; Huryk R; Heston WD; Melamed MR; Whitmore WF
Cancer Res; 1988 Apr; 48(8):2061-3. PubMed ID: 3349477
[TBL] [Abstract][Full Text] [Related]
11. Lomustine treatment of metastatic renal cell carcinoma.
Mittelman A; Albert DJ; Murphy GP
JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
[No Abstract] [Full Text] [Related]
12. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
[TBL] [Abstract][Full Text] [Related]
13. Soft agar clonogenic assay for primary human renal carcinoma: in vitro chemotherapeutic drug sensitivity testing.
Lieber MM; Kovach JS
Invest Urol; 1981 Sep; 19(2):111-4. PubMed ID: 7275551
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of effective vinblastine-sulfate dosage in different renal cell carcinomas after transplantation to the NU/NU mice.
Otto U; Huland H; Klosterhalfen H
Prog Clin Biol Res; 1982; 100():209. PubMed ID: 7145946
[No Abstract] [Full Text] [Related]
15. [Effect of N-alkyl-N-nitrosourea on the protein-synthesizing system of liver and hepatoma 22a cells].
Abakumova OIu; Ugarova TIu; Pilipenko NN; Kutsenko NG; Lerman MI
Biull Eksp Biol Med; 1973 Oct; 75(10):51-4. PubMed ID: 4360614
[No Abstract] [Full Text] [Related]
16. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Moertel CG
Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
[No Abstract] [Full Text] [Related]
17. Treatment of metastatic renal cell carcinoma: review of experience and world literature.
Luderer RC; Opipari MI; Perrotta AL
J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445
[No Abstract] [Full Text] [Related]
18. A new animal model for testing the effectiveness of chemotherapeutic agents on renal adenocarcinoma.
White RD; Previte S; Olsson CA
Surg Forum; 1978; 29():629-31. PubMed ID: 401284
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma.
Kuebler JP; Hogan TF; Trump DL; Bryan GT
Cancer Treat Rep; 1984 Jun; 68(6):925-6. PubMed ID: 6733709
[No Abstract] [Full Text] [Related]
20. [Clinical aspects and chemotherapy of adenocarcinoma of the kidney].
Possinger K; Hartenstein R; Ehrhart H
Fortschr Med; 1981 Mar; 99(12):419-23. PubMed ID: 7227939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
